Key result
Renal transplant recipients show ~81% higher vWF levels and increased platelet reactivity versus healthy controls.
Why the study?
Do renal transplant recipients have increased platelet turnover and reactivity compared to healthy controls?
Cross-Sectional (n=210)
No
Do renal transplant recipients have increased platelet turnover and reactivity compared to healthy controls?
Absolute Event Rate: 195% vs 108%
p-value: p=<0.0001
Renal transplant recipients exhibit higher platelet turnover and reactivity compared to healthy controls, which may contribute to their increased cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
May indicate heightened post-transplant thrombotic risk; leaves open whether targeted antithrombotic strategies improve outcomes.
Marcucci et al. (2010) conducted a cross-sectional in Renal transplant recipients (n=210). Renal transplantation vs. Healthy controls was evaluated on von Willebrand factor (vWF:Ag) levels (%) (p=<0.0001). Renal transplant recipients had significantly higher von Willebrand factor levels (195% vs 108%, p<0.0001) and increased platelet turnover and reactivity compared to healthy controls.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: